Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Science/Tech AI Developer Raises $100M in New Funds

Code on screen

A provider of artificial intelligence services for scientific and advanced technology applications is raising $100 million in its second venture round. . . . → Read More: Science/Tech AI Developer Raises $100M in New Funds

Group Devising Lower Cost Clinical Trials

Doctor with tablet

A new not-for-profit organization aims to create a more efficient process for large-scale randomized clinical trials, to provide reliable results at lower cost. . . . → Read More: Group Devising Lower Cost Clinical Trials

Infographic – Venture Funds More Than Double in 2021

Venture deals and dollars, Q4 2021

Venture funding worldwide rose sharply in 2021, with investment dollars climbing to nearly $621 billion, more than twice the total invested in 2020. . . . → Read More: Infographic – Venture Funds More Than Double in 2021

Trial Shows Gut Probiotic Reduces Covid-19 Disease

Microbiome graphic

Results of a clinical trial show a microbial supplement in the gut reduces respiratory symptoms and viral load in people with mild Covid-19 disease. . . . → Read More: Trial Shows Gut Probiotic Reduces Covid-19 Disease

Biotech, AI Company Partner on Covid-19 Alert System

SARS-CoV-2 particle

A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants. . . . → Read More: Biotech, AI Company Partner on Covid-19 Alert System

Sanofi Partners in $5.3B Precision Drug Discovery Deal

Chemical atom model

A company using artificial intelligence to design drugs for personalized treatments is partnering with drug maker Sanofi in a deal valued at $5.3 billion. . . . → Read More: Sanofi Partners in $5.3B Precision Drug Discovery Deal

Trial Set for Covid-19 Nasal Spray Vaccine

Nasal spray

A clinical trial testing a vaccine to protect against Covid-19 disease, given as a nasal spray, is scheduled to begin later this year in the Netherlands. . . . → Read More: Trial Set for Covid-19 Nasal Spray Vaccine

Trial Underway Testing PTSD Drug Therapy

IED explosion

A clinical trial is underway testing an experimental drug to treat the underlying causes and symptoms of post-traumatic stress disorder or PTSD. . . . → Read More: Trial Underway Testing PTSD Drug Therapy

CEPI Funds Multi-Variant Covid-19 Vaccine

SARS-CoV-2 and cell

Coalition for Epidemic Preparedness Innovations or CEPI is funding a new vaccine to protect against emerging Covid-19 variants and other coronaviruses. . . . → Read More: CEPI Funds Multi-Variant Covid-19 Vaccine

Messenger RNA Developer ETF Launches

Investor screen

A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA. . . . → Read More: Messenger RNA Developer ETF Launches